iLite® C3a Assay Ready Cells
BM4073
The iLite® C3a Assay Ready Cells enable a precise assessment of the C3a peptide levels with high specificity for C3a and with no cross reactivity for C4a, C5a and C3a des-Arg.
Ideal for potency studies of therapeutics that aim at modulating C3a-mediated inflammatory and immune responses including C3aR antagonists and drug candidates acting upstream of C3 cleavage in the complement cascade. C3a is also an essential biomarker and indicator molecule for the evaluation of efficacy and potency of drug candidates acting upstream in the complement cascade through different therapeutic strategies.
- High sensitivity and large dynamic range
- "Assay-ready" format for rapid and convenient use
- Reproducible and biologically relevant results
- Reduced assay variability and higher reproducibility compared to cells in culture
- Normalization of cell counts and serum matrix effects using a second reporter gene
Product Overview
iLite® C3a Assay Ready Cells are human HEK293 cells genetically engineered to be responsive to human complement component 3a (C3a), resulting in a proportional expression of Firefly Luciferase.
This cell line is optimized for the quantification of C3a activity, and for the determination of inhibitory activity against either C3a itself or against the C3a receptor in test samples, including human serum.
Normalization of cell counts and serum matrix effects is obtained by a second reporter gene, a Renilla Luciferase reporter gene construct, under control of a constitutive promoter.
FOR RESEARCH USE ONLY
What's in the box?
>250 µL of Assay Ready Cells suspended in cryoprotective medium.
Specifications
| Product code | BM4073 |
| Assay target | c3a |
| Size | 1 vial corresponding to one 96 well plate |
| Technology | Cell-based reporter gene assay |
| Detection system | Luminescence |
| Regulatory status | Research Use Only |